1928 Diagnostics key facts
as of Oct 2026- Developer of a bioinformatics platform designed to support microbiologists in taking advantage of their sequencing data.
- 1928 Diagnostics is valued at approximately $31.6M as of Oct 2026 (last reported valuation).
- It has raised $12.3M; the latest was Later Stage VC ($310K) in Jul 2025.
- Notable investors include Chalmers Ventures, Chalmers Innovation, Horizon 2020, Sciety.
- Status: Privately Held (backing).
1928 Diagnostics's last reported valuation, Dec 2019. Nothing priced has surfaced since.
- ·Watch 1928 Diagnostics: the Monday email on marks, rounds and moves
1928 Diagnostics funding rounds
No funding rounds for 1928 Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs 1928 Diagnostics
41928 Diagnostics valuation
1928 Diagnostics's last reported valuation was $31.6 million in Dec 2019. No priced round, secondary trade or fund mark has surfaced since.
1928 Diagnostics investors
4 investors are on record for 1928 Diagnostics, including Chalmers Ventures, Chalmers Innovation, Horizon 2020 and Sciety.
About 1928 Diagnostics
Developer of a bioinformatics platform designed to support microbiologists in taking advantage of their sequencing data. The company's platform offers a cloud service for the analysis of genomic data for outbreak tracing and identification of bacteria, and viruses, enabling doctors to effectively track and minimize the spread of bugs globally.
- Sector
- Healthcare
- HQ
- Gothenburg, Sweden
- Founded
- 2013
- Employees
- 12
- Website
- 1928diagnostics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.